• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种短线性肽YI12和FK13对多重耐药菌的抗菌潜力评估

Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria.

作者信息

Sun Jingyi, Kong Pan, Shi Jingru, Liu Yuan

机构信息

Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, China.

Joint International Research Laboratory of Agriculture and Agri-Product Safety, The Ministry of Education of China, Yangzhou University, Yangzhou 225009, China.

出版信息

Pathogens. 2024 Sep 14;13(9):797. doi: 10.3390/pathogens13090797.

DOI:10.3390/pathogens13090797
PMID:39338988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11435022/
Abstract

The accelerating spread of antibiotic resistance has significantly weakened the clinical efficacy of existing antibiotics, posing a severe threat to public health. There is an urgent need to develop novel antimicrobial alternatives that can bypass the mechanisms of antibiotic resistance and effectively kill multidrug-resistant (MDR) pathogens. Antimicrobial peptides (AMPs) are one of the most promising candidates to treat MDR pathogenic infections since they display broad-spectrum antimicrobial activities and are less prone to achieve drug resistance. In this study, we investigated the antibacterial capability and mechanisms of two machine learning-driven linear peptide compounds termed YI12 and FK13. We reveal that YI12 and FK13 exhibit broad-spectrum antibacterial properties against clinically significant bacterial pathogens, inducing no or minimal hemolysis in mammalian red blood cells. We further ascertain that YI12 and FK13 are resilient to heat and acid-base conditions, and exhibit susceptibility to hydrolytic enzymes and divalent cations under physiological conditions. Initial mechanistic investigations reveal that YI12 and FK13 compromise bacterial membrane integrity, leading to membrane potential dissipation and excessive reactive oxygen species (ROS) generation. Collectively, our findings highlight the prospective utility of these two cationic amphiphilic peptides as broad-spectrum antibacterial agents.

摘要

抗生素耐药性的加速传播显著削弱了现有抗生素的临床疗效,对公众健康构成了严重威胁。迫切需要开发新型抗菌替代品,以绕过抗生素耐药机制并有效杀灭多重耐药(MDR)病原体。抗菌肽(AMPs)是治疗MDR病原体感染最有前景的候选物之一,因为它们具有广谱抗菌活性且不易产生耐药性。在本研究中,我们研究了两种机器学习驱动的线性肽化合物YI12和FK13的抗菌能力及其作用机制。我们发现YI12和FK13对临床上重要的细菌病原体具有广谱抗菌特性,在哺乳动物红细胞中不诱导或仅诱导最小程度的溶血。我们进一步确定YI12和FK13对热和酸碱条件具有耐受性,并且在生理条件下对水解酶和二价阳离子敏感。初步的机制研究表明,YI12和FK13破坏细菌膜的完整性,导致膜电位耗散和过量活性氧(ROS)生成。总的来说,我们的研究结果突出了这两种阳离子两亲性肽作为广谱抗菌剂的潜在用途。

相似文献

1
Evaluation of the Antibacterial Potential of Two Short Linear Peptides YI12 and FK13 against Multidrug-Resistant Bacteria.两种短线性肽YI12和FK13对多重耐药菌的抗菌潜力评估
Pathogens. 2024 Sep 14;13(9):797. doi: 10.3390/pathogens13090797.
2
A novel function of short cationic peptide FP-CATH9 without antimicrobial activity reverses resistance to minocycline in common multidrug-resistant gram-negative bacteria.一种无抗菌活性的短阳离子肽FP-CATH9的新功能可逆转常见多重耐药革兰氏阴性菌对米诺环素的耐药性。
Microbiol Spectr. 2025 Apr;13(4):e0290824. doi: 10.1128/spectrum.02908-24. Epub 2025 Feb 25.
3
Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.海洋生物来源的截短型抗菌肽保留了抗癌活性和抗多重耐药金黄色葡萄球菌的抗菌活性。
Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004. Epub 2013 Apr 15.
4
Antimicrobial activity of novel symmetrical antimicrobial peptides centered on a hydrophilic motif against resistant clinical isolates: and analyses.新型对称抗菌肽以亲水基序为中心对耐药临床分离株的抗菌活性: 和 分析。
Microbiol Spectr. 2024 Nov 5;12(11):e0026524. doi: 10.1128/spectrum.00265-24. Epub 2024 Oct 9.
5
In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates.抗菌肽brevinin-2CE与五种抗生素对多重耐药临床分离株的体外协同活性
Curr Microbiol. 2014 Jun;68(6):685-92. doi: 10.1007/s00284-014-0529-4. Epub 2014 Jan 29.
6
Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.通过修饰含非天然氨基酸的两亲性和阳离子肽来提高其抗致病性细菌的抗菌活性。
J Pept Sci. 2010 Nov;16(11):607-12. doi: 10.1002/psc.1270.
7
Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.阳离子抗菌肽:针对耐甲氧西林金黄色葡萄球菌和多重耐药铜绿假单胞菌的抗生素替代品和/或佐剂。
BMC Microbiol. 2019 Mar 8;19(1):54. doi: 10.1186/s12866-019-1416-8.
8
LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.LL-37 衍生的具有细胞膜活性的 FK-13 类似物,具有细胞选择性、抗生物膜活性、与氯霉素协同作用和抗炎活性。
Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037. Epub 2017 Feb 1.
9
Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections.肽类抗菌剂的研究进展:应对新兴耐药感染的一种可能选择。
Adv Colloid Interface Sci. 2024 Nov;333:103282. doi: 10.1016/j.cis.2024.103282. Epub 2024 Sep 6.
10
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.中性二芳基脲化合物 PQ401 可杀死耐抗生素和耐受抗生素的金黄色葡萄球菌。
mBio. 2020 Jun 30;11(3):e01140-20. doi: 10.1128/mBio.01140-20.

引用本文的文献

1
Anti-Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review.抗炎肽作为治疗炎症性肠病的有前景的治疗剂:一项系统评价。
JGH Open. 2025 Jun 29;9(7):e70212. doi: 10.1002/jgh3.70212. eCollection 2025 Jul.

本文引用的文献

1
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.ESKAPE 病原体:抗微生物药物耐药性、流行病学、临床影响和治疗学。
Nat Rev Microbiol. 2024 Oct;22(10):598-616. doi: 10.1038/s41579-024-01054-w. Epub 2024 Jun 3.
2
Relationship between antimicrobial peptides-induced cell membrane damage and bactericidal activity.抗菌肽诱导的细胞膜损伤与杀菌活性之间的关系。
Biophys J. 2023 Dec 19;122(24):4645-4655. doi: 10.1016/j.bpj.2023.11.006. Epub 2023 Nov 10.
3
Challenges and advances in antimicrobial peptide development.
抗菌肽研发的挑战与进展。
Drug Discov Today. 2023 Aug;28(8):103629. doi: 10.1016/j.drudis.2023.103629. Epub 2023 May 23.
4
Antimicrobial peptides´ immune modulation role in intracellular bacterial infection.抗菌肽在细胞内细菌感染中的免疫调节作用。
Front Immunol. 2023 Mar 28;14:1119574. doi: 10.3389/fimmu.2023.1119574. eCollection 2023.
5
Bacterial proton motive force as an unprecedented target to control antimicrobial resistance.细菌质子动力作为控制抗菌耐药性的空前靶点。
Med Res Rev. 2023 Jul;43(4):1068-1090. doi: 10.1002/med.21946. Epub 2023 Mar 10.
6
The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections.抗菌肽 LI14 可对抗多重耐药菌感染。
Commun Biol. 2022 Sep 7;5(1):926. doi: 10.1038/s42003-022-03899-4.
7
Identification of antimicrobial peptides from the human gut microbiome using deep learning.利用深度学习从人类肠道微生物组中识别抗菌肽。
Nat Biotechnol. 2022 Jun;40(6):921-931. doi: 10.1038/s41587-022-01226-0. Epub 2022 Mar 3.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Antimicrobials Functioning through ROS-Mediated Mechanisms: Current Insights.通过ROS介导机制发挥作用的抗菌剂:当前见解
Microorganisms. 2021 Dec 28;10(1):61. doi: 10.3390/microorganisms10010061.
10
Correction: The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.更正:抗菌肽的多面性:当前的合成化学方法及未来方向。
Chem Soc Rev. 2022 Jan 24;51(2):792. doi: 10.1039/d1cs90109e.